Which hedge funds own RCKT? ROCKET PHARMACEUTICALS INC, Q2 2026 13F holders
Healthcare · Open on the interactive board
9 of the hedge funds tracked by WhaleCreep disclosed a position in RCKT (ROCKET PHARMACEUTICALS INC) in their Q2 2026 13F filings, worth $51.7m in total. The largest holder by portfolio weight is Maverick Capital at 0.1% of its book. 1 manager opened a new position this quarter: Citadel Advisors.
9tracked managers holding
1opened this quarter
0exited this quarter
Which hedge funds hold RCKT? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Maverick Capital | Q2 2026 | 0.1% | $13.4m | 3,923,963 | 10% | added |
| Marshall Wace | Q2 2026 | 0.0% | $13.8m | 4,029,262 | 33% | added |
| Millennium Management | Q2 2026 | 0.0% | $13.7m | 4,000,344 | 28% | added |
| Woodline Partners | Q2 2026 | 0.0% | $2.2m | 641,222 | 0% | held |
| Renaissance Technologies LLC | Q2 2026 | 0.0% | $2.7m | 792,974 | 24% | added |
| Point72 Asset Management LP | Q2 2026 | 0.0% | $2.3m | 670,527 | -34% | reduced |
| D. E. Shaw & Co | Q2 2026 | 0.0% | $3.3m | 950,552 | -56% | reduced |
| Tudor Investment | Q2 2026 | 0.0% | $172.7k | 50,493 | 0% | held |
| Citadel Advisors | Q2 2026 | 0.0% | $243.4k | 71,170 | – | new |
How has hedge fund ownership of RCKT changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 9 | $51.7m |
| Q1 2026 | 8 | $51.0m |
| Q4 2025 | 5 | $22.7m |
| Q3 2025 | 5 | $41.7m |
| Q2 2025 | 6 | $34.7m |
| Q1 2025 | 6 | $67.9m |
| Q4 2024 | 8 | $147.2m |
| Q3 2024 | 6 | $107.5m |
| Q2 2024 | 5 | $128.8m |
| Q1 2024 | 3 | $140.4m |
| Q4 2023 | 4 | $183.4m |
| Q3 2023 | 4 | $157.7m |
| Q2 2023 | 5 | $120.0m |
| Q1 2023 | 6 | $128.1m |
| Q4 2022 | 6 | $155.8m |
| Q3 2022 | 4 | $87.2m |
Counts every tracked manager that disclosed RCKT in that quarter's filing, including managers that have since stopped filing.